Erik Davis says: I recently published my first column for Aeon Magazine's online site, a "post-secular" take on the current wave of psychedelic research. Without plunging into woo, the article attempts to chart the liminal zones that lie beyond brain-based reductionism. It seemed a good piece for Aeon, a new British outfit that is charting a very interesting zone between science, religion, culture, and good writing.
Studies recently carried out at Yale, and published last month in the journal Science, have confirmed earlier reports that ketamine offers remarkable, nearly instantaneous relief for people who suffer from forms of major depression impervious to other treatment methods. Interpreting depression as a hardware problem largely caused by the loss of synaptic connections, the researchers argue that ketamine works by encouraging sprightly neural growth in brain regions correlated with memory and mood. Journalistic reports also linked this research with the development of a new vein of antidepressants, including Naurex’s GLYX-13, that have the neurone-fertilising power of ketamine without, as one report describes them, the ‘schizophrenia-like effects’.
Rarely has the new neuro-reductionism been so naked in its repackaging of human experience. Nowhere in the research or the journalism does anyone suggest that heavily depressed people feel better because ketamine sends them on a first-person voyage through profound, sometimes ecstatic, and certainly mind-bending modes of transpersonal consciousness whose subjective power might itself boot the mind out of its most mirthless ruts.
Return trip: A new generation of researchers is heading into the weird world of psychedelic drugs. It could change their minds
Jan Hoffman writes about recent research into the effects on psychedelics such as psilocybin on anxiety and depression: “About 80 percent of cancer patients showed clinically significant reductions in both psychological disorders, a response sustained some seven months after the single dose.” Dr. Jeffrey Lieberman, a past president of the American Psychiatric Association, and Dr. […]
Johns Hopkins is among several institutions challenging a key tenet of outlawing psychedelics: that they have “no medicinal use.” Baltimore Magazine examines the progress made by key researchers Roland Griffiths and Bill Richards.
Once the domain of countercultural psychonauts, LSD and mushrooms in one-tenth doses are becoming more popular among you professionals, especially in the tech industry.
Traditional folding wallets are designed for paper bills—but these days, carrying cash is rarely a necessity. More often than not, I don’t carry cash at all. This Bogui Clik Wallet is the best answer I’ve found for avoiding the hassle of those tight-fitting credit card pockets.This attractive, minimalist wallet features a protective lip, so my cards don’t […]
Using my iPhone while it’s charging is always a hassle. With tucked-away outlets and the meager length of included lightning cables, comfortable scrolling while plugged in is annoying. These 10-Ft MFi-Certified Lightning Cables are super convenient and probably the best iPhone accessory purchase I’ve made.At over three times the length of normal cables, these reach anywhere you […]
With countless applications for modern life, artificial intelligence (AI) is one of the most in-demand fields of study in tech. Beyond modelling human decision making processes and learning abilities, AI can be used to analyze massive volumes of data and create complex interactive systems.This Machine Learning & AI for Business Bundle made mastering these concepts possible for […]